medigraphic.com

2015, Number S3

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2015; 53 (S3)

Cardiovascular risk factors in children with primary nephrotic syndrome

Alegría-Torres GA, Aguilar-Kitsu MA, Estrada-Loza MJ, Villasís-Keeverd Á

Language: Spanish
References: 26
Page: 284-293
PDF size: 363.92 Kb.


ABSTRACT

Background: It has been suggested that patients with nephrotic syndrome (NS) have an increased frequency of cardiovascular risk factors. The aim of this study was to determine the frequency of cardiovascular risk factors in children with primary NS.
Methods: Cross-sectional, descriptive and prospective study. Fifty-five patients with primary NS were included. The presence of overweight/ obesity, hypertension, dyslipidemias, hyperglycemia, elevated C-reactive protein and carotid intima-media thickness (IMT) was evaluated. The treatment time, the type of treatment and the number of relapses were analyzed. For statistical analysis chi-square and Spearman’s rho were used.
Results: The most frequent cardiovascular risk factor was increased carotid IMT (98.1 %), followed by hypertriglyceridemia (54.4 %) and total cholesterol (40 %). Patients with corticosensitive NS had fewer risk factors compared with patients with steroid-resistant NS. There was also a positive correlation of longer time of evolution and number of relapses with the increase in the number of factors.
Conclusions: Ninety-eight % of children with primary NS had at least one cardiovascular risk factor. Certain clinical features, such as steroidresistant NS, and the time of evolution and treatment, seem to be related to the presence of larger number of risk factors.


REFERENCES

  1. Santos F. Síndrome nefrótico. Na Pediatr Contin. 2004;2:223-9.

  2. Academia Mexicana de Pediatría, Comité de Expertos en Nefrología. Síndrome nefrótico en niños. Bol Med Hosp Infant Mex. 2000;57:522-36.

  3. Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO ClinicalPracticeGuidelineforGlomerulonephritis. Kidney inter. Suppl. 2012;2:139-274.

  4. Instituto Mexicano del Seguro Social. Guía práctica clínica diagnóstico y tratamiento del síndrome nefrótico primário en niños. México: Instituto Mexicano del Seguro Social; 2013.

  5. Gipson DS, Massengill SF, Yao L, Nagari S, Smoyer W, Mahan J, et al. Management of childhood honest nephrotic syndrome. Pediatrics. 2009;124:747-57.

  6. Gordillo R, Spitzer A. The nephrotic syndrome. Pediatr. Rev. 2009;30:94-105.

  7. Ksiazek J, Ciechanowicz A, Wierzbicka A. Is dyslipidemia sustained during remission of nephritic syndrome genetically determined?. Pol Arch Med Wewn. 2009;119(1-2):11-6.

  8. Kavey RE, Allada V, Daniels SR, Hayman LL, Mc- Crindle BW, Newburger JW, et al. Cardiovascular risk reduction in high risk pediatric patients. Circulation. 2006;114:2710-38.

  9. Morrison K, Aronson L, Gray-McGuire C. Metabolic syndrome in childhood predicts adults cardiovascular disease 25 years later: the Princeton lipid research clinics follow study. Pediatrics. 2007;120(2):340-5.

  10. Rifai N, Ridker P. High sensitivity C reactive protein: a novel and promising marker of coronary heart disease. Clin Chem. 2001;47(3):403-11.

  11. Macini J, Dahlöf B, Diez J. Surrogate markers for cardiovascular disease, structural markers. Circulation. 2004;109(25):22-30.

  12. Lacquaniti A, Bolignano D, Donato V, Bono C, Fazio MR, Buemi M. Alterations of lipid metabolism in chronic nephropathies: mechanisms, diagnosis and treatment. Kidney Blood Press Res. 2010;33:100-10.

  13. McMahan CA, Gidding SS, Malcom GT, Tracy RE, Strong JP, McGil HC Jr. Pathobiological determinants of atherosclerosis in youth risk scores are associated with early and advanced atherosclerosis. Pediatrics. 2006;118(4):1447-55.

  14. Tkaczyk M, Czupryniak A, Owczarek D, Lukamowics J, Nowicki M. Markers of endothelial dysfunction in children with idiopathic nephrotic syndrome. Am J Nephrol. 2008;28(2):197-201.

  15. Pelkowska A, Sancewicz-Pach K. Determination of endothelial function in children with nephrotic syndrome in various states of disease. Wiad Lek. 2005;58(1):35-8.

  16. Ksiazek J, Niemirska A, Lipka M, Grenda R. Evaluation of arterial intima-media thickness (IMT) in children with idiopathic nephrotic syndrome. Przegl Lek. 2006; 63 (3):205-7.

  17. Nakamura A, Niimi R, Kurosaki K, Yanagawa Y. Factors influencing cardiovascular risk following termination of glucocorticoid therapy for nephrotic syndrome. Clin Exp Nephrol. 2010;14(5):457-62.

  18. Daniels SR, Greer FR. Lipid screening and cardiovascular health in childhood. Pediatrics. 2008;122(1):198-208.

  19. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the Diagnosis, evaluation and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114:555-76.

  20. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, et al. Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the advisory board of the 3rd and 4th watching the risk symposium, 13th and 15th European stroke conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis. 2007(1);23:75-80.

  21. Shroff R, Dégi A, Kerti A, Kis E, Cseprekál O, Tory K, et al. Cardiovascular risk assessment in children with chronic kidney disease. Pediatr Nephrol. 2013;28(6):875-84.

  22. Candan C, Canpolat N, Gökalp S, Yildiz N, Turhan P, Tasdemir M, et al. Subclinical cardiovascular disease and its association with risk factors in children with steroid-resistant nephrotic syndrome. Pediatr Nephrol. 2014;29(1):95-102.

  23. Hooman N, Isa-Tafreshi R, Otukesh H, Mostafavi SH, Hallaji F. Carotid artery function in children with idiopathic nephrotic syndrome. Nefrologia. 2013;33(5):650-6.

  24. Lande MB, Pearson TA, Vermilion RP, Auinger P, Fernandez ID. Elevated blood pressure, race/ethnicity, and C-reactive protein levels in children and adolescents. Pediatrics. 2008;122(6):1252-7.

  25. Acevedo M, Arnáiz P, Barja S, Bambs C, Berríos X, Guzmán B et al. Proteína C reactiva y su relación con adiposidad, factores de riesgo cardiovascular y aterosclerosis subclínica en niños sanos. Rev Esp Cardiol. 2007;60:1051-8.

  26. Lechner BL, Bockenhauer D, Iragorri S, Kennedy TL, Siegel NJ. The risk of cardiovascular disease in adults who have had childhood nephrotic syndrome. Pediatr Nephrol. 2004;19(7):744-8.




2020     |     www.medigraphic.com